Stress management and meditative movements for depression with physical symptoms in Asian Americans
Official title: Integrating the Stress Management and Resiliency Training (SMART) With Qigong/Tai Chi (QTC) to Develop a Holistic Treatment for Asian Americans With Depression and Distressing Somatic Symptoms
Run by Massachusetts General Hospital · NCT07610928 · Data updated 2026-11-12
This study tests whether combining the SMART program with meditative movements like Qigong/Tai Chi can help Asian American adults with major depression who also have physical symptoms.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | Massachusetts General Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | September 1, 2026 |
| Main results expected | March 31, 2027 |
| Study ends | August 31, 2027 |
| Registry record updated | October 7, 2026 |
| Trial ID | NCT07610928 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Aged 18 or older, self-identifying as Asian, with DSM-5 diagnosed major depressive disorder and significant physical symptoms, and no recent mind-body practice.
✕Probably not a fit
Individuals who cannot participate in mind-body activities or have unstable psychiatric treatment may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults who identify as Asian and have major depressive disorder with significant physical symptoms will participate in a combined program of Stress Management and Resiliency Training (SMART) and Qigong/Tai Chi, compared to standard care. The trial will evaluate practicality, acceptability, and safety of the combined approach over a fixed period while keeping medications and psychotherapy stable. Participants will undergo clinical interviews, symptom questionnaires, and basic cognitive screening at baseline and follow-ups. The focus is on whether this mind-body combination can address both mood and somatic symptoms in this population.
Why it matters
Potential benefit: If successful, participants may experience improvements in mood and physical symptoms, with a feasible, acceptable approach for integration into care.
How similar studies have gone: Prior mind-body approaches have shown benefits for depression, but combining SMART with Qigong/Tai Chi in this population is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Self-identify as being of Asian ethnicity * English language proficiency * Be ≥18 years of age * Satisfy DSM-5 criteria for MDD prior to the initiation of the study intervention, as determined by a clinical interview conducted by the Principal Investigator (PI) during screening using DSM-5 diagnostic criteria. * A baseline of the Patient-Reported Outcomes Measurement Information System (PROMIS) Depression score ≥ 16 * A baseline score of PHQ-15 ≥10 * Have not had Tai Chi/Qigong training/practice or other forms of mind-body intervention (e.g. yoga, mindfulness training, muscle relaxation training, etc) more than once a week in the past 3 months * A total score 24 or higher in Mini-Mental Status Examination for cognitive ability (if the participant endorses a history of cognitive impairment). * Willing to keep any psychiatric medications and psychotherapy stable throughout the course of the study (from Week 0 baseline to Week 12 Follow-up) * Have access to a device (i.e., smartphone, iPad, personal computer) and a stable network to attend the online group sessions * Ability to perform daily physical activity Exclusion Criteria: * Have a primary psychiatric diagnosis other than MDD * Any history of psychosis, mania, or impulsivity and difficulty relating to people and judged by the clinician not appropriate for group intervention * Active eating disorder or substance use disorder within the last 6 months * Any relevant medical conditions that may be the medical basis of depression including thyroid diseases, epilepsy, history of an abnormal EEG, severe head trauma, or stroke * Have serious uncontrolled medical conditions (e.g. poorly controlled diabetes, severe congestive heart failure), or other medical conditions that in the opinion of the investigators represents a risk to the subject, including presence of a pacemaker, cardiac arrhythmia, fever, weakness and hypotension, or vagal nerve stimulator * current active suicidal or self-injurious potential (i.e., PHQ-9 item 9 ≥1 and/or a positive response to C-SSRS screener items 3, 4, 5, or 6), and assessed by the clinician necessitating immediate treatment * Participant who are or who plan to receive confounding treatments (including treatment of endocrinopathies): use of antidepressants, complementary and alternative medical (CAM) treatments thought to have beneficial effects on mood, including St. John's Wort, S-Adenosyl methionine (SAMe), omega-3 fatty acids, light therapy, conventional psychotherapy, mind-body interventions (e.g. Qigong, mindfulness training, muscle relaxation training, etc.) * Electroconvulsive therapy (ECT) during the last year as these patients are often among the more refractory and are not optimal candidates for CAM * History of refractory to treatment with ≥3 failed antidepressant trials in current depressive episode * Participated in other depression-related clinical trials within the past 3 months * Antidepressant or psychiatric medications that are initiated less than 8 weeks or a dose change less than 4 weeks prior to screening visit * Psychotherapy that has been initiated within the past 3 months
Where it's running
-
Depression Clinical and Research Program
Boston, Massachusetts, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding how the orbitofrontal cortex guides approach vs. avoidance in depression
This study tests how different parts of the orbitofrontal cortex influence whether people pursue rewards or risk loss, and whether this pattern is altered in Major Depressive Disorder.
-
Health education program to help depression in older adults and caregivers in Ho Chi Minh City
A community-based education program for people 60+ and their caregivers is being tested to see if it can lower depression and improve quality of life compared with standard care.
-
Prucalopride for low mood: testing a 5-HT4 receptor activator for cognition and sleep
This study tests whether prucalopride, a 5-HT4 receptor drug, can improve thinking and sleep in adults with low mood or major depressive disorder compared to a placebo.
-
Pre-visit Companion Brief: a primary care AI-assisted check for depression and anxiety
This pilot tests an AI-powered pre-visit assessment that creates a concise Companion Brief for clinicians to help identify depression and anxiety during routine primary care.
-
Medically tailored groceries to help depression in people with food insecurity
This trial tests whether giving medically tailored groceries for six months can reduce depressive symptoms in adults who have depression and struggle with access to food.
-
AI-powered personalized exercise plan for older adults using a wearable app
A wearable-enabled, AI-driven exercise app is tested to see if it’s feasible and acceptable for adults 65+ and whether it can help increase activity, improve mood, and boost quality of life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.